Clinical Trials on Blood Eosinophil Count in New Zealand

Total 11928 results

JOTEC GmbH

Recruiting

A PMCF Study in Patients With Thoracoabdominal Aortic Aneurysms Treated With E-nside TAAA Multibranch Stent Graft System (INNER-B-APAC)

Thoracoabdominal Aortic Aneurysm

New Zealand, Thailand, Australia
Intellia Therapeutics

Active, not recruiting

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)

Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy | Wild-Type Transthyretin Cardiac Amyloidosis

France, United Kingdom, New Zealand, Sweden
Vascular Innovations Co. Ltd.
MedPass International

Active, not recruiting

A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve

Aortic Valve Stenosis

New Zealand, Hong Kong, Thailand, Greece, Lithuania, Poland
Aligos Therapeutics

Terminated

A Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects

Chronic Hepatitis B

New Zealand, Bulgaria, Moldova, Republic of, Romania
ViiV Healthcare

Completed

Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants

HIV Infections

United States, New Zealand
Rijnstate Hospital

Withdrawn

Post Implant Syndrome After EVAR and EVAS (INSPIRE Study)

Inflammatory Response | Abdominal Aortic Aneurysm

New Zealand, Netherlands, Spain, Germany, Poland
TransAortic Medical, Inc.

Completed

transShield Embolic Protection System Feasibility Study

Aortic Stenosis

New Zealand, Venezuela
Naestved Hospital
Statens Serum Institut

Completed

Plasma Transfusion in Major Vascular Surgery

Arterial Occlusive Diseases | Aortic Aneurysm, Abdominal

Denmark
Intellia Therapeutics

Enrolling by invitation

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Hereditary Angioedema

France, New Zealand, United Kingdom, Netherlands
ONL Therapeutics

Active, not recruiting

A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients With Progressing Open Angle Glaucoma

Open Angle Glaucoma

Australia, New Zealand
Boston Scientific Corporation

Completed

FAST Feasibility Study

Coronary Artery Disease

Australia, Latvia, New Zealand
University of Copenhagen
Bispebjerg Hospital; Lundbeck Foundation; Region Capital Denmark; Bevica Fonden; Danish... and other collaborators

Completed

Electrical Stimulation of the Paretic Upper Limb in the Early Stroke Phase

Stroke, Acute

Denmark
GlaxoSmithKline

Terminated

Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome

Hypereosinophilic Syndrome

United States, Belgium, Canada, Germany, Italy, France, Australia
Gilead Sciences

Completed

Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment

HCV Infection

United States, New Zealand, Germany
Rijnstate Hospital
W.L.Gore & Associates

Active, not recruiting

Iliac Branch Excluder ReGistry (IceBERG) (IceBERG)

Aneurysm | Abdominal Aortic Aneurysms | Common Iliac Aneurysms

Italy, New Zealand, Netherlands, Spain
Lars Møller Pedersen
Zealand University Hospital; Weill Medical College of Cornell University; Herlev... and other collaborators

Recruiting

Characterization and Clinical Impact of the Gut Microbiota in Lymphoma

Diffuse Large B Cell Lymphoma

Denmark
Gilead Sciences

Completed

Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment

Hepatitis B Virus

United States, Germany, New Zealand
Alios Biopharma Inc.
Vertex Pharmaceuticals Incorporated

Terminated

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic

Australia, New Zealand
PQ Bypass, Inc.

Unknown

DETOUR I Clinical Study

Peripheral Arterial Disease

Italy, Chile, Germany, Latvia, New Zealand, Poland
Symic Vascular
Symic Biomedical, Inc.

Unknown

Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis (SHIELD)

Peripheral Arterial Disease

Australia, New Zealand
Arrowhead Pharmaceuticals

Completed

Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)

Hepatitis B

Australia, Hong Kong, New Zealand
Hoffmann-La Roche

Completed

A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both

Hepatitis B, Chronic

Taiwan, United States, New Zealand, Singapore
Hoffmann-La Roche

Completed

A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies

Hepatitis B, Chronic

Taiwan, United States, New Zealand, Singapore
GlaxoSmithKline

Completed

A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622

Hypereosinophilic Syndrome

United States, Poland, Spain, France, Belgium, Germany, Argentina, Russian Federation, Mexico, Italy, Brazil, United Kingdom, Romania
Prehospital Center, Region Zealand

Completed

Drowning-related OHCA in Denmark: A Six-year Registry-based Study

Out-Of-Hospital Cardiac Arrest | Drowning

Denmark
GlaxoSmithKline

Completed

Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)

Hypereosinophilic Syndrome | Hypereosinophilia

United States, Belgium, Canada, Germany, Italy, France, Switzerland, Australia
GlaxoSmithKline

Completed

Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)

Hypereosinophilic Syndrome

United States, Poland, Spain, France, Belgium, Germany, Argentina, Russian Federation, Mexico, Italy, Brazil, United Kingdom, Romania
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, New Zealand, Korea, Republic of, Italy
Klinikum Rosenheim
Charite University, Berlin, Germany; Medtronic; University Hospital Tuebingen; Herz-Zentrums... and other collaborators

Unknown

CHOCO-CABANA Trial

Atherosclerosis

New Zealand, Austria, Germany
Janssen Research & Development, LLC

Terminated

A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection

Hepatitis C

Singapore, Canada, Poland, New Zealand
Gilead Sciences

Completed

Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment

Hepatitis C Virus

United States, New Zealand
PolyActiva Pty Ltd

Active, not recruiting

Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma

Open Angle Glaucoma

Australia, New Zealand
Endologix

Active, not recruiting

Nellix Registry Study: EVAS-Global (EVAS FORWARD 2)

Abdominal Aortic Aneurysm

New Zealand, Spain, Germany, Netherlands
Cook Group Incorporated

Completed

Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE)

Peripheral Arterial Disease (PAD)

Germany, New Zealand
C. R. Bard

Terminated

Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower Extremity (LEG)

Peripheral Artery Disease

Malaysia, New Zealand, Canada
Alere San Diego

Completed

Heart Failure (HF) Outpatient Monitoring Evaluation (HOME) Study (HOME)

Heart Failure | Acute Decompensated Heart Failure | Systolic Heart Failure

United Kingdom, Australia, New Zealand, Sweden, Ireland, Netherlands
Trek Therapeutics, PBC

Completed

A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

Chronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral Infection

United States, New Zealand
Abbott Medical Devices

Completed

Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) (HOMEOSTASIS)

Heart Failure

United States, Australia, New Zealand
OcuNexus Therapeutics, Inc.

Completed

A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study)

Venous Ulcer

New Zealand, United States
Medtronic Cardiovascular
Medtronic Australasia

Completed

CoreValve® System Australia/New Zealand Clinical Study

Aortic Valve Stenosis

New Zealand, Australia
Kirby Institute
AbbVie

Completed

Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P (TARGET3D)

Hepatitis C, Acute

United Kingdom, Australia, New Zealand
Sunnybrook Health Sciences Centre
Canadian Institutes of Health Research (CIHR)

Completed

Multicentre Radial Artery Patency Study: Results of Patency Beyond 5 Years After Coronary Artery Bypass Surgery (RAPS - 5 years)

Coronary Artery Disease

New Zealand, Canada
ReCode Therapeutics

Recruiting

Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects

Primary Ciliary Dyskinesia

United Kingdom, United States, Australia, New Zealand
Prehospital Center, Region Zealand

Completed

Accidental Hypothermia in Drowning-related OHCA

Hypothermia Due to Cold Environment | Out-Of-Hospital Cardiac Arrest | Drowning | Hypothermia, Accidental

Denmark
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils

Asthma | Elevated Blood Eosinophils | Oral Corticosteroid Dependence

United States, Argentina, Australia, Belgium, Czechia, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Spain, Ukraine
SurModics, Inc.

Completed

Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon (SWING)

Peripheral Arterial Disease | Critical Lower Limb Ischemia

New Zealand, Australia, Austria, Germany, Latvia
National Cancer Institute (NCI)

Completed

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditions

United States
Shockwave Medical, Inc.

Completed

Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+)

Peripheral Arterial Disease | Vascular Disease, Peripheral

New Zealand, Australia, United States
Abbott Medical Devices

Completed

Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study (zLAP)

Heart Failure

United States, New Zealand
Gilead Sciences

Active, not recruiting

Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B

Chronic Hepatitis B

Taiwan, New Zealand

Clinical Trials on Blood Eosinophil Count in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations